[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"$fHn6CO66oQLSLLodasPY4f2PgRehkT7dB0V-dj0eI0YU":3},{"sponsor":4,"sponsorVariants":5,"totalTrials":6,"truncated":7,"activeTrials":8,"phase3Count":9,"totalEnrollment":10,"activePrograms":11,"nonDrugCount":12,"topConditions":13,"upcomingReadouts":33,"phaseBuckets":44,"rows":51},"Connecticut Children's Medical Center",[4],58,false,17,0,7390,3,50,[14,17,20,22,24,27,29,31],{"name":15,"count":16},"Sickle Cell Disease",6,{"name":18,"count":19},"Pain",4,{"name":21,"count":11},"Asthma",{"name":23,"count":11},"Bronchiolitis",{"name":25,"count":26},"Pain, Chronic",2,{"name":28,"count":26},"Pediatric Cancer",{"name":30,"count":26},"Status Asthmaticus",{"name":32,"count":26},"Inflammatory Bowel Disease",[34,39],{"nctId":35,"briefTitle":36,"date":37,"intervention":38},"NCT05898087","Subpectoral Bupivacaine for Pain Management in Adolescent Reduction Mammaplasty","2026-04-01","Marcaine 0.25 % Injectable Solution",{"nctId":40,"briefTitle":41,"date":42,"intervention":43},"NCT05781152","Clinical, Imaging, and Endoscopic Outcomes of Children Newly Diagnosed With Crohn's Disease","2028-07-01","Anti-TNF therapy",[45,46,47,48,49,50],"EARLY_PHASE1","PHASE1","PHASE2","PHASE3","PHASE4","NA",[52,77,95,117,142,169,187,205,233,257,283,301,327,345],{"intervention":38,"totalTrials":53,"cells":54},1,{"EARLY_PHASE1":55,"PHASE1":57,"PHASE2":59,"PHASE3":61,"PHASE4":63,"NA":75},{"trials":56,"activeCount":9},[],{"trials":58,"activeCount":9},[],{"trials":60,"activeCount":9},[],{"trials":62,"activeCount":9},[],{"trials":64,"activeCount":53,"soonestReadout":37},[65],{"nctId":35,"briefTitle":36,"status":66,"phases":67,"primaryCompletion":37,"completion":37,"start":68,"enrollment":69,"conditions":70,"interventions":73},"RECRUITING",[49],"2022-04-01",128,[71,72],"Macromastia","Post-operative Pain",[38,74],"Saline",{"trials":76,"activeCount":9},[],{"intervention":74,"totalTrials":53,"cells":78},{"EARLY_PHASE1":79,"PHASE1":81,"PHASE2":83,"PHASE3":85,"PHASE4":87,"NA":93},{"trials":80,"activeCount":9},[],{"trials":82,"activeCount":9},[],{"trials":84,"activeCount":9},[],{"trials":86,"activeCount":9},[],{"trials":88,"activeCount":53,"soonestReadout":37},[89],{"nctId":35,"briefTitle":36,"status":66,"phases":90,"primaryCompletion":37,"completion":37,"start":68,"enrollment":69,"conditions":91,"interventions":92},[49],[71,72],[38,74],{"trials":94,"activeCount":9},[],{"intervention":43,"totalTrials":53,"cells":96},{"EARLY_PHASE1":97,"PHASE1":99,"PHASE2":101,"PHASE3":103,"PHASE4":105,"NA":115},{"trials":98,"activeCount":9},[],{"trials":100,"activeCount":9},[],{"trials":102,"activeCount":9},[],{"trials":104,"activeCount":9},[],{"trials":106,"activeCount":53,"soonestReadout":42},[107],{"nctId":40,"briefTitle":41,"status":66,"phases":108,"primaryCompletion":42,"completion":109,"start":110,"enrollment":111,"conditions":112,"interventions":114},[49],"2029-07-01","2023-06-10",900,[113],"Crohn Disease",[43],{"trials":116,"activeCount":9},[],{"intervention":118,"totalTrials":53,"cells":119},"terbutaline",{"EARLY_PHASE1":120,"PHASE1":122,"PHASE2":124,"PHASE3":126,"PHASE4":128,"NA":140},{"trials":121,"activeCount":9},[],{"trials":123,"activeCount":9},[],{"trials":125,"activeCount":9},[],{"trials":127,"activeCount":9},[],{"trials":129,"activeCount":9},[130],{"nctId":131,"briefTitle":132,"status":133,"phases":134,"primaryCompletion":135,"completion":135,"start":136,"enrollment":137,"conditions":138,"interventions":139},"NCT00124995","Trial of Terbutaline for the Treatment of Status Asthmaticus in Children","COMPLETED",[49],"2006-10","2003-10",40,[30],[118],{"trials":141,"activeCount":9},[],{"intervention":143,"totalTrials":53,"cells":144},"Mesalazine",{"EARLY_PHASE1":145,"PHASE1":147,"PHASE2":149,"PHASE3":151,"PHASE4":153,"NA":167},{"trials":146,"activeCount":9},[],{"trials":148,"activeCount":9},[],{"trials":150,"activeCount":9},[],{"trials":152,"activeCount":9},[],{"trials":154,"activeCount":9},[155],{"nctId":156,"briefTitle":157,"status":133,"phases":158,"primaryCompletion":159,"completion":159,"start":160,"enrollment":161,"conditions":162,"interventions":164},"NCT01536535","Predicting Response to Standardized Pediatric Colitis Therapy",[49],"2018-04-30","2012-07-10",431,[163],"Ulcerative Colitis",[143,165,166],"IV Corticosteroid","Oral Corticosteroids",{"trials":168,"activeCount":9},[],{"intervention":165,"totalTrials":53,"cells":170},{"EARLY_PHASE1":171,"PHASE1":173,"PHASE2":175,"PHASE3":177,"PHASE4":179,"NA":185},{"trials":172,"activeCount":9},[],{"trials":174,"activeCount":9},[],{"trials":176,"activeCount":9},[],{"trials":178,"activeCount":9},[],{"trials":180,"activeCount":9},[181],{"nctId":156,"briefTitle":157,"status":133,"phases":182,"primaryCompletion":159,"completion":159,"start":160,"enrollment":161,"conditions":183,"interventions":184},[49],[163],[143,165,166],{"trials":186,"activeCount":9},[],{"intervention":166,"totalTrials":53,"cells":188},{"EARLY_PHASE1":189,"PHASE1":191,"PHASE2":193,"PHASE3":195,"PHASE4":197,"NA":203},{"trials":190,"activeCount":9},[],{"trials":192,"activeCount":9},[],{"trials":194,"activeCount":9},[],{"trials":196,"activeCount":9},[],{"trials":198,"activeCount":9},[199],{"nctId":156,"briefTitle":157,"status":133,"phases":200,"primaryCompletion":159,"completion":159,"start":160,"enrollment":161,"conditions":201,"interventions":202},[49],[163],[143,165,166],{"trials":204,"activeCount":9},[],{"intervention":206,"totalTrials":53,"cells":207},"Lactobacillus acidophilus and Bifidobacterium lactis",{"EARLY_PHASE1":208,"PHASE1":210,"PHASE2":212,"PHASE3":227,"PHASE4":229,"NA":231},{"trials":209,"activeCount":9},[],{"trials":211,"activeCount":9},[],{"trials":213,"activeCount":9},[214],{"nctId":215,"briefTitle":216,"status":217,"phases":218,"primaryCompletion":219,"completion":219,"start":220,"enrollment":9,"conditions":221,"interventions":226},"NCT02535962","Probiotics and Corticosteroids for Treating Periodic Fever, Aphthous Stomatitis, Pharyngitis, Cervical Adenitis (PFAPA)","WITHDRAWN",[47],"2017-09","2016-10",[222,223,224,225],"Periodic Fever","Aphthous Stomatitis","Pharyngitis","Cervical Adenitis",[206],{"trials":228,"activeCount":9},[],{"trials":230,"activeCount":9},[],{"trials":232,"activeCount":9},[],{"intervention":234,"totalTrials":53,"cells":235},"ketamine",{"EARLY_PHASE1":236,"PHASE1":238,"PHASE2":240,"PHASE3":251,"PHASE4":253,"NA":255},{"trials":237,"activeCount":9},[],{"trials":239,"activeCount":9},[],{"trials":241,"activeCount":9},[242],{"nctId":243,"briefTitle":244,"status":245,"phases":246,"primaryCompletion":247,"completion":247,"start":248,"enrollment":11,"conditions":249,"interventions":250},"NCT00595530","Low-Dose Ketamine Infusion for Children With Sickle Cell Disease-Related Pain","TERMINATED",[47],"2010-02-12","2008-03-04",[15],[234],{"trials":252,"activeCount":9},[],{"trials":254,"activeCount":9},[],{"trials":256,"activeCount":9},[],{"intervention":258,"totalTrials":53,"cells":259},"Furosemide",{"EARLY_PHASE1":260,"PHASE1":273,"PHASE2":275,"PHASE3":277,"PHASE4":279,"NA":281},{"trials":261,"activeCount":9},[262],{"nctId":263,"briefTitle":264,"status":133,"phases":265,"primaryCompletion":266,"completion":266,"start":267,"enrollment":268,"conditions":269,"interventions":271},"NCT05098366","Furosemide Use to Fill the Bladder of Pediatric Females Awaiting Pelvic Ultrasound",[45],"2023-12-31","2021-05-29",42,[270],"Ovarian Torsion",[258,272],"Normal saline",{"trials":274,"activeCount":9},[],{"trials":276,"activeCount":9},[],{"trials":278,"activeCount":9},[],{"trials":280,"activeCount":9},[],{"trials":282,"activeCount":9},[],{"intervention":272,"totalTrials":53,"cells":284},{"EARLY_PHASE1":285,"PHASE1":291,"PHASE2":293,"PHASE3":295,"PHASE4":297,"NA":299},{"trials":286,"activeCount":9},[287],{"nctId":263,"briefTitle":264,"status":133,"phases":288,"primaryCompletion":266,"completion":266,"start":267,"enrollment":268,"conditions":289,"interventions":290},[45],[270],[258,272],{"trials":292,"activeCount":9},[],{"trials":294,"activeCount":9},[],{"trials":296,"activeCount":9},[],{"trials":298,"activeCount":9},[],{"trials":300,"activeCount":9},[],{"intervention":302,"totalTrials":53,"cells":303},"Genomic DNA",{"EARLY_PHASE1":304,"PHASE1":306,"PHASE2":308,"PHASE3":310,"PHASE4":312,"NA":314},{"trials":305,"activeCount":9},[],{"trials":307,"activeCount":9},[],{"trials":309,"activeCount":9},[],{"trials":311,"activeCount":9},[],{"trials":313,"activeCount":9},[],{"trials":315,"activeCount":9},[316],{"nctId":317,"briefTitle":318,"status":133,"phases":319,"primaryCompletion":320,"completion":320,"start":321,"enrollment":322,"conditions":323,"interventions":324},"NCT02984059","Study Assessing Risk Factors for Abdominal Pain in Children With Inflammatory Bowel Disease",[],"2018-08-01","2015-10-21",126,[32],[302,325,326],"RNA analysis","Microbiome",{"intervention":325,"totalTrials":53,"cells":328},{"EARLY_PHASE1":329,"PHASE1":331,"PHASE2":333,"PHASE3":335,"PHASE4":337,"NA":339},{"trials":330,"activeCount":9},[],{"trials":332,"activeCount":9},[],{"trials":334,"activeCount":9},[],{"trials":336,"activeCount":9},[],{"trials":338,"activeCount":9},[],{"trials":340,"activeCount":9},[341],{"nctId":317,"briefTitle":318,"status":133,"phases":342,"primaryCompletion":320,"completion":320,"start":321,"enrollment":322,"conditions":343,"interventions":344},[],[32],[302,325,326],{"intervention":326,"totalTrials":53,"cells":346},{"EARLY_PHASE1":347,"PHASE1":349,"PHASE2":351,"PHASE3":353,"PHASE4":355,"NA":357},{"trials":348,"activeCount":9},[],{"trials":350,"activeCount":9},[],{"trials":352,"activeCount":9},[],{"trials":354,"activeCount":9},[],{"trials":356,"activeCount":9},[],{"trials":358,"activeCount":9},[359],{"nctId":317,"briefTitle":318,"status":133,"phases":360,"primaryCompletion":320,"completion":320,"start":321,"enrollment":322,"conditions":361,"interventions":362},[],[32],[302,325,326]]